A

Akeso
9926

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$86.03B
EV
HK$82.35B
Shares Outstanding
897.81M
Beta
0.52

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$96.17
P/E 2025E
256.19x
P/Revenue 2025E
22.15x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Akeso, Inc.

gainify

A

Akeso, Inc.

9926

Akeso, Inc., a biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs. The company develops AK104, a PD-1/CTLA-4 bi-specific antibody to treat cervical cancer, gastric cancer (GC), gastroesophageal junction (GEJ) cancer, ESCC,...

Sector

Healthcare

Industry

Biotechnology

CEO

Xia, Yu

Employees

3,035

IPO Date

2020-04-24

Headquarters

No. 6, Shennong Road, Torch Development Zone, Zhongshan, Guangdong Province, 528437, China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.